Normalisation is medical misogyny and delays diagnosis
Sharnelle Vella, ABC Radio Melbourne breakfast co-host[/caption]
Mike Stephens, Director, Medicines policy and Programs at the National Aboriginal Community Controlled Health Organisation (NACCHO)[/caption]
Chastina Heck MPS, Chair of the PSA/NACCHO Aboriginal and Torres Strait Islander Pharmacy Practice Community of Specialty Interest (CSI).[/caption]
Philippa Chigeza, pharmacist at Logan Hospital.[/caption]
NSW pharmacists given special authority to supply essential medicines
NSW has granted pharmacists a landmark special authority to supply most S4 medicines without a prescription to those affected by bushfires.
The NSW Chief Health...
New alliance between PSA and SHPA announced
At PSA19 this morning, it was revealed that a Memorandum of Understanding (MoU) was signed by PSA and the Society of Hospital Pharmacists of...
Complementary medicines: Rheumatoid arthritis
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by joint inflammation. The immune system attacks the tissue lining the joints (synovial membrane), causing...
From the President: PSA at the FIP World Congress in Seville,...
I have just returned from FIP’s World Congress of Pharmacy and Pharmaceutical Sciences in Seville, where PSA CEO Mark Kinsela, PSA Senior Pharmacist Peter...
From the President: For 25 years, accreditation has paved the way
For some, it may be hard to believe; but this month marks 25 years since the start of pharmacist accreditation for medication review in Australia.
The pain of uncertainty: Managing pain without codeine
With over-the-counter (OTC) codeine products being upscheduled, pharmacists and pharmacy staff need to review and understand every patient’s pain. In doing so, there’s an...
